The stock's fall snapped a two-day winning streak.

Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with ...

With talk about the sell-off of Thermo Fisher Scientific’s TMO shares by institutional investors and company insiders, market sentiment toward the company seems bearish. The stock has lost 12.7% in ...

Thermo Fisher Scientific Inc.’s TMO strategic buyouts and partnerships are poised to help it grow in the upcoming quarters. The company continues to prioritize its partnership with customers to drive ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $537.23 which represents a slight increase of $7.87 or 1.49% from the prior close of $529.36. The stock opened at ...

Shares of Thermo Fisher Scientific Inc. TMO advanced 1.63% to $529.36 Friday, on what proved to be an all-around mixed ...

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, ...

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

Thermo Fisher Scientific is acquiring Olink, a company that provides proteomics analysis tools and services used in drug discovery research. Olink’s growing revenue will help shore up a Thermo ...

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.